Biohaven Ltd. ( (BHVN) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Biohaven Ltd. saw its stock price fluctuate significantly after the company withdrew its marketing application for troriluzole in Europe, causing market reactions. Additionally, the appointment of CEO Vlad Coric to the board of Royalty Pharma may have strategic implications. These developments, along with a notable gain by a call buyer, contributed to the unusual stock movements.
More about Biohaven Ltd.
YTD Price Performance: -37.23%
Average Trading Volume: 1,256,242
Technical Sentiment Signal: Buy
Current Market Cap: $2.39B
For further insights into BHVN stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.